Metabolism of flavonolignans in human hepatocytes
Language English Country England, Great Britain Media print-electronic
Document type Journal Article
PubMed
29414024
DOI
10.1016/j.jpba.2018.01.048
PII: S0731-7085(17)32879-0
Knihovny.cz E-resources
- Keywords
- Bactosomes, Cytochrome P450, Hepatocytes, LC/MS, Silybin, Silymarin,
- MeSH
- Biotransformation physiology MeSH
- Adult MeSH
- Flavonolignans metabolism MeSH
- Hepatocytes metabolism MeSH
- Middle Aged MeSH
- Humans MeSH
- Aged MeSH
- Silybin MeSH
- Silymarin analogs & derivatives metabolism MeSH
- Cytochrome P-450 Enzyme System metabolism MeSH
- Tandem Mass Spectrometry methods MeSH
- Chromatography, High Pressure Liquid methods MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Names of Substances
- dehydrosilybin MeSH Browser
- Flavonolignans MeSH
- isosilybin A MeSH Browser
- Silybin MeSH
- Silymarin MeSH
- Cytochrome P-450 Enzyme System MeSH
This study examined the in vitro biotransformation of eight structurally related flavonolignans, namely silybin, 2,3-dehydrosilybin, silychristin, 2,3-dehydrosilychristin, silydianin, 2,3-dehydrosilydianin, isosilybin A and isosilybin B. The metabolic transformations were performed using primary cultures of human hepatocytes and recombinant human cytochromes P450 (CYPs 1A2, 2A6, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 and 3A4). The metabolites produced were analyzed by ultra-performance liquid chromatography coupled with tandem mass spectrometry. We found that each of the tested compounds was metabolized in vitro by one or more CYP enzymes, which catalyzed O-demethylation, hydroxylation, hydrogenation and dehydrogenation reactions. In human hepatocytes, silybin, 2,3-dehydrosilybin, silychristin, 2,3-dehydrosilychristin, and isosilybins A and B were directly conjugated by sulfation or glucuronidation. Moreover, isosilybin A was also converted to a methyl derivative, while isosilybin B was hydroxylated and methylated. Silydianin and 2,3-dehydrosilydianin were found to undergo hydrogenation and/or glucuronidation. In addition, 2,3-dehydrosilydianin was found to be metabolically the least stable flavonolignan in human hepatocytes, and its main metabolite was a cleavage product corresponding to a loss of CO. We conclude that the hepatic biotransformation of flavonolignans primarily involves the phase II conjugation reactions, however in some cases the phase I reactions may also occur. These results are highly relevant for research focused on flavonolignan metabolism and pharmacology.
References provided by Crossref.org
Chirality Matters: Biological Activity of Optically Pure Silybin and Its Congeners
Identification of Human Sulfotransferases Active towards Silymarin Flavonolignans and Taxifolin
Biotransformation of Silymarin Flavonolignans by Human Fecal Microbiota
Sulfated Metabolites of Flavonolignans and 2,3-Dehydroflavonolignans: Preparation and Properties
In-Vitro Activity of Silybin and Related Flavonolignans against Leishmania infantum and L. donovani